Clinical Trial Update: P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies [Phase 3]

View source ↗

Summary

Phase 3 trial of umbilical cord blood cells expanded with MPCs for transplantation in hematologic malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Hodgkin Disease
• Non-hodgkin Lymphoma

Drugs mentioned

• umbilical cord blood cells expanded with MPCs

Snippet

Sponsor: Mesoblast, Ltd. | Conditions: Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia | Phase 3 | Status: COMPLETED